 NEW ORLEANS--BUSINESS WIRE--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick Foti, LLC KSF are investigating the proposed sale of Urovant Sciences NasdaqGS: UROV to Sumitovant Biopharma. Under the terms of the proposed transaction, shareholders of Urovant will receive only 16.25 in cash for each share of Urovant that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whethe 